Peptic esophageal strictures are a common sequelae of long-standing re
flux esophagitis. Factors predisposing to stricture formation are poor
ly understood; however, stricture patients are typically older, have a
longer duration of reflux symptoms, have significantly lower lower es
ophageal sphincter pressures, and more frequently display abnormal eso
phageal motility than reflux patients without strictures. A careful hi
story should suggest the diagnosis in most cases, but should be confir
med with a barium esophagram followed by endoscopy with biopsies to ex
clude malignancy. The therapeutic armamentarium for treating peptic st
rictures has greatly expanded during the past 30 yr. It now includes p
otent anti-secretory medications, bougienage with flexible polyethylen
e dilators or balloons, and anti-reflux surgery. Aggressive medical th
erapy combined with bougienage is safe and effective treatment for the
majority of stricture patients, with surgery being reserved for the s
ubset of patients with intractable esophagitis, irreversibly damaged e
sophagus, or extraesophageal manifestations.